German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May ...

Merck KGaA lowered its medium-term outlook for its healthcare and life-science segment due to China challenges and recent ...

German science and technology company Merck lowered mid-term targets for its Life Sciences and Healthcare businesses, ...

Belen Garijo, the CEO of Merck KGaA, says focus on growth and innovation is key to the German group’s future.

German science and technology giant Merck on Thursday said it is confident of returning to medium-term growth after a ...

Merck's recent decline is due to reduced profit guidance and FDA decisions, but shares are at a support level. Read why I ...

Ken Frazier and Ken Chenault said companies retreating from DEI will limit equal opportunities for disadvantaged Americans.

Merck’s investigational antibody clesrovimab demonstrated more than 60% effectiveness in reducing some types of respiratory ...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility ...

Former Merck CEO Ken Frazier and former American Express CEO Ken Chenault have warned companies pulling back from diversity, ...

Merck said the Phase 2b/3 pivotal study evaluating a single dose of clesrovimab administered to healthy preterm and full-term infants met all prespecified endpoints, with consistent results through ...

Merck & Co. hopes a new positive trial readout can return Keytruda to glory in head and neck cancer. | Merck & Co. hopes a ...